Medical Care in China

Colorectal cancer
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Comprehensive coverage of digestive diseases, includinggastrointestinal, hepatobiliary, pancreatic, and anorectal diseases, all of which can be assessed.
Endoscopic precision diagnosis and treatmentis used for examination, biopsy and some minimally invasive treatments.
Complex digestive surgerycovers gastrointestinal tumors, intestinal obstruction, and complex abdominal diseases.
Multidisciplinarycollaborative assessment involving internal medicine, surgery, imaging, and oncology teams.

Condition Guide

About Colorectal cancer

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Colorectal cancer is a malignant tumor that occurs in the colon or rectum. In its early stages, it often presents with no obvious symptoms, but as the disease progresses, symptoms such as rectal bleeding, changes in bowel habits, abdominal pain, and weight loss may appear. Its occurrence is often related to the long-term evolution of intestinal polyps, dietary structure, genetics, and age. Screening methods such as colonoscopy can detect and treat the cancer at an early stage, even in the precancerous stage. Treatment primarily involves surgery, combined with chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Most patients in the early and middle stages have a good prognosis with standardized treatment.

Cutting-edge high-precision diagnostic and treatment technologies

  1. Neoadjuvant Therapy ( TNT) for Rectal Cancer : For locally advanced rectal cancer, total neoadjuvant therapy (TNT) is used, moving chemotherapy and radiotherapy entirely before surgery. The West China Hospital TNT-TRT Phase III study (JCO, 2026) showed that the induction-concurrent-consolidation "sandwich" CAPOX regimen achieved a 3-year disease-free survival rate of 74.8% and a pathological complete response rate of approximately 26%.
  2. Neoadjuvant immunotherapy for dMMR : For patients with mismatch repair deficiency (dMMR/MSI-H), neoadjuvant therapy with the PD-1 inhibitor pembrolizumab is administered preoperatively. The IMHOTEP trial showed that approximately 53% of patients achieved pathological complete remission after 1-2 cycles, and some patients could even avoid or reduce the need for surgery.
  3. Precision-targeted therapy : Select targeted drugs according to genotype: RAS/BRAF wild-type can be combined with anti-EGFR monoclonal antibody cetuximab β (CSCO colorectal cancer guidelines updated in 2025); BRAF V600E mutation can be treated with caninefenib combined with cetuximab ± chemotherapy (ASCO 2025 reported that this can prolong survival).
  4. Robotic Minimally Invasive Radical Resection : Low rectal cancer can be treated with sphincter-preserving radical resection using laparoscopy and robotic techniques (including domestically produced single-port robotic surgery) via natural orifice septum retrieval (NOSES). The First Affiliated Hospital of Anhui Medical University completed the world's first sphincter-preserving resection of low rectal cancer with simultaneous liver metastasis using a domestically produced single-port robotic surgery in 2025.
  5. Local Removal of Liver Metastases : For synchronous or metachronous liver metastases, conversion therapy is followed by laparoscopic liver resection combined with intraoperative microwave ablation and other local treatments. The Sixth Affiliated Hospital of Sun Yat-sen University (reported in 2026) achieved tumor-free survival through precise resection and ablation of multiple liver metastases.

Care Overview

Colorectal cancer Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Li Jingnan

Professor , specializing in colorectal cancer screening and neuroendocrine tumors

Gastroenterology

Research areas: carcinogenesis mechanisms, clinical screening and prevention of colon polyps and colorectal cancer; neuroendocrine tumors of the gastrointestinal pancreas. Cutting-edge technology: Long-term research on the treatment of colon polyps and the screening, prevention, and carcinogenesis mechanisms of colorectal cancer (Visiting Scholar at Massachusetts General Hospital, Harvard Medical School). Led the compilation of national expert consensus on neuroendocrine tumors and gastrointestinal mucosa

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Ni Quanxing

Chief Physician, Professor, Founder of the Discipline

Gastroenterology

Research areas : Basic and clinical research on pancreatic tumors, comprehensive treatment of advanced pancreatic cancer; Cutting-edge technology: Establishment of a multidisciplinary diagnosis and treatment system for pancreatic cancer; Areas of expertise: Pancreatic cancer, ampullary cancer, and tumors at the bile duct-pancreatic junction; Academic highlights: A leading authority on pancreatic tumors in China, and Director of the Academic Committee of the Shanghai Pancreatic Tumor Institute; Core values

Fudan University Cancer Hospital logo Affiliated Hospital Fudan University Cancer Hospital
Ji Ming

Professor – Specializing in Interventional Digestive Endoscopy

Gastroenterology

Research areas: Endoscopic interventional (minimally invasive) diagnosis and treatment of digestive diseases, including endoscopic diagnosis and treatment of early gastrointestinal cancers, pancreatic and biliary diseases, and gastrointestinal bleeding. Cutting-edge technology: Proficient in interventional (minimally invasive) endoscopic diagnosis and treatment of digestive tract cancers, with extensive experience in endoscopic treatment of early gastrointestinal cancers and pancreatic and biliary disease

Beijing Friendship Hospital (Second Clinical Medical College), Capital Medical University logo Affiliated Hospital Beijing Friendship Hospital (Second Clinical Medical College), Capital Medical University
Wu Bin

Specializing in Colorectal Tumor Surgery and Inflammatory Bowel Disease

Gastroenterology

Research areas: Surgical treatment of colorectal tumors and surgical treatment of inflammatory bowel disease. Cutting-edge technology: Participated in laparoscopic minimally invasive surgery for colorectal cancer and surgical treatment of inflammatory bowel disease in the professional group, and participated in multiple national multicenter clinical studies. Specializes in treating: colorectal cancer, inflammatory bowel disease (Crohn's disease, ulcerative colitis), and intestinal obstruction. Academic Hi

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Li Peng

Chief Physician, Professor, Director of the Digestive Center

Gastroenterology

Research areas : early gastrointestinal cancer, endoscopic ultrasound (EUS), pancreatic and biliary diseases; Cutting-edge technology: EUS for precise diagnosis of pancreatic tumors and intramural lesions of the gastrointestinal tract; Areas of expertise: early esophageal/gastric cancer, pancreatic lesions, common bile duct stones; Academic highlights: Dean of the School of Digestive Health, Capital Medical University; Core value: Establishing standardized clinical pathways for early gastrointestinal canc

Beijing Friendship Hospital (Second Clinical Medical College), Capital Medical University logo Affiliated Hospital Beijing Friendship Hospital (Second Clinical Medical College), Capital Medical University
Xu Jin

Chief Physician, Professor

Gastroenterology

Research Areas : Neoadjuvant conversion therapy for pancreatic cancer, peritoneal metastasis of pancreatic cancer; Cutting-edge Technology: Neoadjuvant therapy for pancreatic cancer + HIPEC (hyperthermic intraperitoneal perfusion) combined regimen; Areas of Expertise: Locally advanced pancreatic cancer, peritoneal metastasis of pancreatic cancer, periampullary cancer; Academic Highlights: Key expert in pancreatic cancer conversion therapy; Core Value: Improved screening criteria for conversion surgery in

Fudan University Cancer Hospital logo Affiliated Hospital Fudan University Cancer Hospital

Patient Stories

See the Next Step Through Patient Journeys

Giant Pancreatic Pseudocyst : A Hidden Danger After an CASE 01
PATIENT JOURNEY

Giant Pancreatic Pseudocyst : A Hidden Danger After an "Emergency" - How a Russian Patient Dissolved a Fluid-Filled Sac in His Abdomen Using "Scarless" Endoscopic Techniques in China

Gastroenterology

Patient records Name: Elena Age: 62 years old Nationality: Russian Diagnosis: Recovery phase of severe acute pancreatitis, giant pancreatic pseudocyst (15cm in diameter). Treatment hospital: Department of Pancreatic Surgery, West China Hospital, Sichuan University. After surviving the life-or-death ordeal of acute pancreatitis, some patients face a troublesome sequela — pancreatic pseudocysts. This fluid-filled "sac" is like a time bomb, potentially causing infection, rupture, or compression of surroundi

View case details →
Chronic Pancreatitis : A German Engineer's Journey to Pain Relief - How We Helped Him End Years of Severe Pain Using Endoscopic Techniques CASE 02
PATIENT JOURNEY

Chronic Pancreatitis : A German Engineer's Journey to Pain Relief - How We Helped Him End Years of Severe Pain Using Endoscopic Techniques

Gastroenterology

Patient records Name: Hans Age: 52 years old Nationality: German Diagnosis: Chronic alcoholic pancreatitis, multiple pancreatic duct stones, dilation of the main pancreatic duct (diameter >1cm), and intractable abdominal pain. Treatment Hospital: Pancreatic Center, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine For patients with chronic pancreatitis, the recurring, deep-seated abdominal pain is an indescribable torment. Hans's story tells how he ended years of pain in China

View case details →
Crohn's Disease-Related Bowel Obstruction : How a British Patient Finds a CASE 03
PATIENT JOURNEY

Crohn's Disease-Related Bowel Obstruction : How a British Patient Finds a "Balance on a Knife's Edge" in China When "Green Cancer" Repeatedly Causes Obstruction

GastroenterologySurgery

Patient records Name: David Age: 35 Nationality: British Diagnosis: Crohn's disease (ileocolic type, stricture type), recurrent small bowel obstruction Treatment Hospital: Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Crohn's disease, known as the "green cancer," is incurable and recurrent, leading to serious complications such as intestinal stenosis, perforation, and fistulas. David's story tells how he found a precise balance between "over-operation" and "recurrent obstr

View case details →

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.